Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Yield10 Bioscience Inc YTEN

Healthcare Biotechnology

Yield10 Bioscience, Inc. is an agricultural bioscience company that is leveraging advanced genetics to develop the oilseed Camelina sativa (Camelina) as a platform crop for large-scale production of sustainable seed products. These seed products include feedstock oils for renewable diesel and sustainable aviation biofuels; omega-3 (EPA and DHA+EPA) oils for pharmaceutical, nutraceutical and... see more

Add To Watchlist

Recent & Breaking News (OTCQB:YTEN)

Yield10 Bioscience to Announce Fourth Quarter and Full Year 2019 Financial Results and Host a Conference Call on Thursday, March 19, 2020

GlobeNewswire March 12, 2020

Yield10 Bioscience Achieves Key Milestones in Early Development Program in Corn to Evaluate Novel Traits

GlobeNewswire March 10, 2020

Yield10 Bioscience Appoints Agriculture Industry Veteran Sherri M. Brown, Ph.D., to Board of Directors

GlobeNewswire February 13, 2020

Yield10 Bioscience Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement

GlobeNewswire January 31, 2020

Yield10 Bioscience Submits "Am I Regulated?" Letter to USDA-APHIS BRS for CRISPR Genome-Edited C3007 in Camelina to Pave the Way for U.S. Field Tests

GlobeNewswire January 16, 2020

Yield10 Bioscience Announces 1-for-40 Reverse Stock Split

GlobeNewswire January 15, 2020

Yield10 Bioscience Announces Closing of $11.5 Million Equity Offering and Full Exercise of Over-allotment Option

GlobeNewswire November 19, 2019

Yield10 Bioscience Announces Pricing of $10.75 Million Equity Offering

GlobeNewswire November 15, 2019

Yield10 Bioscience Announces Third Quarter 2019 Financial Results

GlobeNewswire November 12, 2019

Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present at the 7th Plant Genomics & Gene Editing Congress

GlobeNewswire November 5, 2019

Yield10 Bioscience Signs Research Agreement with J. R. Simplot to Evaluate New Traits to Produce High Yielding, Sustainable Potato Crop

GlobeNewswire October 23, 2019

Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Highlight Camelina Platform for Producing PHB Biomaterials to Improve Water Quality at International Scientific Conference

GlobeNewswire October 4, 2019

Yield10 Bioscience Expands Research License with Bayer for Evaluation of a Novel C3004 Yield Trait Gene in Soybean

GlobeNewswire August 19, 2019

Yield10 Bioscience Announces Second Quarter 2019 Financial Results

GlobeNewswire August 12, 2019

Yield10 Bioscience Announces Notice of Allowance for U.S. Patent Covering Crop Yield Trait C4001

GlobeNewswire August 12, 2019

Yield10 Bioscience to Announce Second Quarter 2019 Financial Results and Host a Conference Call on Monday, August 12, 2019

GlobeNewswire August 6, 2019

Yield10 Bioscience Granted U.S. Patent Covering Crop Yield Trait C3003

GlobeNewswire August 5, 2019

Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present at the Plant Biology 2019 Conference

GlobeNewswire August 1, 2019

Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Highlight Unique Aspects of the Company's GRAIN Technology Platform to Identify Novel Traits for Crops at the 3rd Precision CRISPR & NBT AgBio Congress

GlobeNewswire June 24, 2019

Yield10 Bioscience Files U.S. Patent Application Covering New Technology Enabling Low-cost Production of PHA-based Biomaterials in Camelina

GlobeNewswire June 17, 2019